• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者抗凝血酶III活性降低可能与非酶糖基化有关——初步报告。

Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report.

作者信息

Ceriello A, Dello Russo P, Zuccotti C, Florio A, Nazzaro S, Pietrantuono C, Rosato G B

出版信息

Thromb Haemost. 1983 Oct 31;50(3):633-4.

PMID:6648886
Abstract

Antithrombin III activity was moderately but significantly decreased in insulin dependent diabetics (p less than 0.005), while no difference has been found between the diabetic (n = 25) and control groups (n = 22) in antithrombin III plasma concentration. Moreover, antithrombin III activity was inversely correlated with glycosylated plasma proteins (r = 0.57; p less than 0.01). These data show that in diabetes there is a depressed biological activity of antithrombin III and suggest that this reflects nonenzymatic glycosylation of antithrombin III protein.

摘要

胰岛素依赖型糖尿病患者的抗凝血酶III活性中度但显著降低(p<0.005),而糖尿病组(n = 25)和对照组(n = 22)的抗凝血酶III血浆浓度无差异。此外,抗凝血酶III活性与糖化血浆蛋白呈负相关(r = 0.57;p<0.01)。这些数据表明,糖尿病患者存在抗凝血酶III生物活性降低的情况,提示这反映了抗凝血酶III蛋白的非酶糖基化。

相似文献

1
Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report.糖尿病患者抗凝血酶III活性降低可能与非酶糖基化有关——初步报告。
Thromb Haemost. 1983 Oct 31;50(3):633-4.
2
Daily rapid blood glucose variations may condition antithrombin III biologic activity but not its plasma concentration in insulin-dependent diabetes. A possible role for labile non-enzymatic glycation.在胰岛素依赖型糖尿病中,每日快速的血糖变化可能会影响抗凝血酶III的生物活性,但不会影响其血浆浓度。不稳定的非酶糖基化可能起到一定作用。
Diabete Metab. 1987 Feb;13(1):16-9.
3
Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation.代谢控制可能改变抗凝血酶III的活性,但不会改变糖尿病患者血浆中其浓度:非酶糖基化可能起作用。
Diabetes Care. 1986 Jan-Feb;9(1):32-5. doi: 10.2337/diacare.9.1.32.
4
Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics.
Haemostasis. 1986;16(6):458-64. doi: 10.1159/000215325.
5
Antithrombin III activity and concentration in diabetes mellitus.
Thromb Haemost. 1985 Aug 30;54(2):415-7.
6
Depressed antithrombin III biological activity in opiate addicts.阿片类药物成瘾者抗凝血酶III生物活性降低。
J Clin Pathol. 1984 Sep;37(9):1040-2. doi: 10.1136/jcp.37.9.1040.
7
Functional activities and nonenzymatic glycosylation of plasma proteinase inhibitors in diabetes.糖尿病患者血浆蛋白酶抑制剂的功能活性与非酶糖基化作用
Clin Chim Acta. 1986 Oct 15;160(1):55-62. doi: 10.1016/0009-8981(86)90335-9.
8
Demonstration of altered antithrombin III activity due to nonenzymatic glycosylation at glucose concentration expected to be encountered in severely diabetic patients.
Diabetes. 1988 Aug;37(8):1103-7. doi: 10.2337/diab.37.8.1103.
9
The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus.高血糖诱导的抗凝血酶III改变及因子X激活在糖尿病患者凝血酶活性亢进中的作用
Diabet Med. 1990 May;7(4):343-8. doi: 10.1111/j.1464-5491.1990.tb01402.x.
10
Studies on glycosylated plasma proteins in diabetic patients.糖尿病患者糖化血浆蛋白的研究。
J Pak Med Assoc. 1991 Jan;41(1):16-8.

引用本文的文献

1
Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.正常白蛋白尿和早期肾病的2型糖尿病患者的生理性凝血抑制剂及凝血酶原片段F1+2
Acta Diabetol. 1996 Sep;33(3):241-5. doi: 10.1007/BF02048551.
2
Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects.糖尿病中的凝血激活:高血糖的作用及治疗前景
Diabetologia. 1993 Nov;36(11):1119-25. doi: 10.1007/BF00401055.
3
The role of endothelium in the pathogenesis of diabetic microangiopathy.
内皮细胞在糖尿病微血管病变发病机制中的作用。
Acta Diabetol. 1993;30(4):190-200. doi: 10.1007/BF00569929.
4
Depressed antithrombin III biological activity in opiate addicts.阿片类药物成瘾者抗凝血酶III生物活性降低。
J Clin Pathol. 1984 Sep;37(9):1040-2. doi: 10.1136/jcp.37.9.1040.
5
Aspirin and non-enzymatic glycation.
Acta Diabetol Lat. 1987 Apr-Jun;24(2):171-2. doi: 10.1007/BF02742856.
6
Impaired insulin response to glucose but not to arginine in heroin addicts.海洛因成瘾者对葡萄糖的胰岛素反应受损,但对精氨酸的胰岛素反应未受损。
J Endocrinol Invest. 1986 Oct;9(5):353-7. doi: 10.1007/BF03346942.
7
Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts.
Acta Diabetol Lat. 1987 Jul-Sep;24(3):205-12. doi: 10.1007/BF02732039.
8
Endothelial cell function in diabetic microangiopathy.糖尿病微血管病变中的内皮细胞功能
Diabetologia. 1987 Aug;30(8):601-9. doi: 10.1007/BF00277315.
9
Opioid peptides and metabolic regulation.阿片肽与代谢调节。
Diabetologia. 1988 Jan;31(1):3-15. doi: 10.1007/BF00279126.
10
Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity.
Acta Diabetol Lat. 1989 Apr-Jun;26(2):147-54. doi: 10.1007/BF02581366.